Biotin Immunoaffinity HPLC Column

The Biotin Immunoaffinity HPLC Column is For Research Use Only

Size: 3ml, 10 columns

Assay Principle

Many methods of biotin determination based on HPLC-UV (High Performance Liquid Chromatography Ultraviolet) detection may show either low sensitivity or low selectivity. This depends on the dilution factor of the matrices and if problematic matrices are applied.  This method of content determination of Biotin combines the high selectivity of affinity columns with its potential to concentrate elute and use high sensitivity biotin detection by post-column labeling with fluorescein- streptavidin conjugate.

Sample Preparation:
Biotin samples are to be extracted and analyzed with the method of Bachas et al. [N.G. Hentz, L.G. Bachas Methods Enzymol. 1997; 279:275-86], e.g. vitamin tablets, liquid vitamin preparations, cell culture extracts. Example: 25g vitamin containing tablets are dissolved in 100ml  PBS. The resulting extract may be filtered through a 0.45µm membrane filter.
Enrichment Step IAC:
4ml extract (containing the quantity of Biotin from a 1g sample of above-mentioned sample preparation is followed) is diluted with a total volume of 20ml PBS and then applied in a reservoir on top of the BioTeZ-Immunoaffinity Column. The optimal flow rate through the gel is between 1 to 3ml/min.

---

Related Products

Folic Acid Immunoaffinity Column
Fumonisin Immunoaffinity HPLC Column
Estradiol Immunoaffinity HPLC Column
Product Developed and Manufactured in Germany by BioTeZ Berlin-Buch GmbH

EagleBio的5α-雄甾烷-3α，17β-二醇葡糖醛酸化物是C19类固醇，缩写为3α-DiolG，5α二醇G或简称为α二醇G。它主要作为睾丸激素和二氢睾丸激素（DHT）的代谢产物生产。它主要在目标外围组织（例如皮肤）中产生，尤其是在毛囊周围。大量的3α-DiolG刺激会导致过多的头发形成，特别是在女性通常不存在头发的地方。近年来，在研究患有特发性多毛症的妇女的临床研究人员中，人们对这种类固醇的测量越来越感兴趣。已知是3α-DiolG前体的类固醇包括脱氢表雄酮（DHEA），硫酸脱氢表雄酮（DHEAS），二氢睾丸酮（DHT），雄烯二酮和睾丸激素。已显示只有3α-DiolG随多毛症增加而随治疗减少。这种相关性在多囊卵巢综合征（PCO）患者中也得到了证明。3α-DiolG的测定因此被证明是多种方式的有用指标，包括监测特发性多毛症和PCO妇女的治疗进展。此外，接受环孢霉素A治疗的糖尿病患者（无论男女）均显示3α-DiolG水平升高，这种副作用导致以前无毛的区域出现了头发。3α-DiolG的测定因此被证明是多种方式的有用指标，包括监测特发性多毛症和PCO妇女的治疗进展。此外，接受环孢霉素A治疗的糖尿病患者（无论男女）均显示3α-DiolG水平升高，这种副作用导致以前无毛的区域出现了头发。3α-DiolG的测定因此被证明是多种方式的有用指标，包括监测特发性多毛症和PCO妇女的治疗进展。此外，接受环孢霉素A治疗的糖尿病患者（无论男女）均显示3α-DiolG水平升高，这种副作用导致以前无毛的区域出现了头发。